Lord, Abbett & Co. LLC Bio N Tech Se Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $76.4 Million - $140 Million	-605,251 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $131 Million - $219 Million	605,251 New	605,251 $156 Million
Q1 2021 May 11, 2021	SELL	$85.73 - $119.5 $20.9 Million - $29.2 Million	-244,253 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$72.71 - $129.54 $7.87 Million - $14 Million	-108,290 Reduced 30.72%	244,253 $19.9 Million
Q3 2020 Nov 12, 2020	BUY	$57.81 - $104.17 $20.4 Million - $36.7 Million	352,543 New	352,543 $24.4 Million

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.